Bo Guo

1.9k total citations
52 papers, 1.4k citations indexed

About

Bo Guo is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bo Guo has authored 52 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 10 papers in Pathology and Forensic Medicine and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bo Guo's work include Cancer-related molecular mechanisms research (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Immunotherapy and Immune Responses (5 papers). Bo Guo is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Immunotherapy and Immune Responses (5 papers). Bo Guo collaborates with scholars based in China, United States and Canada. Bo Guo's co-authors include Janet L. Stein, André J. van Wijnen, Jane B. Lian, Yongsheng Li, Bo Zhu, Xiao Han, Gary S. Stein, Peng Lü, Xiaohong Chen and Gary S. Stein and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Bo Guo

50 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Guo China 16 733 386 231 191 135 52 1.4k
Zhijun Ma China 20 726 1.0× 316 0.8× 240 1.0× 375 2.0× 95 0.7× 43 1.4k
Akira Kitanaka Japan 23 751 1.0× 465 1.2× 392 1.7× 165 0.9× 92 0.7× 80 1.7k
Naoko Okayama Japan 20 643 0.9× 403 1.0× 188 0.8× 288 1.5× 148 1.1× 70 1.3k
Leopold Ludwig Germany 17 512 0.7× 445 1.2× 365 1.6× 187 1.0× 173 1.3× 37 1.4k
Matthew J. Oberley United States 20 866 1.2× 485 1.3× 102 0.4× 210 1.1× 157 1.2× 108 1.7k
Hildegard Keppeler Germany 19 671 0.9× 277 0.7× 522 2.3× 98 0.5× 138 1.0× 43 1.7k
Mary Ann Zimmerman United States 21 982 1.3× 305 0.8× 275 1.2× 180 0.9× 138 1.0× 35 1.6k
Yushiro Endo Japan 17 529 0.7× 223 0.6× 500 2.2× 232 1.2× 103 0.8× 99 1.4k
Clyde Riley Australia 23 651 0.9× 466 1.2× 351 1.5× 250 1.3× 186 1.4× 36 1.8k

Countries citing papers authored by Bo Guo

Since Specialization
Citations

This map shows the geographic impact of Bo Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Guo more than expected).

Fields of papers citing papers by Bo Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Guo. The network helps show where Bo Guo may publish in the future.

Co-authorship network of co-authors of Bo Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Guo. A scholar is included among the top collaborators of Bo Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Guo. Bo Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, B., Zhiyuan Guo, Shuang Liu, et al.. (2025). Dosimetric characterization of the laser-accelerated high-energy electron beam for radiotherapy applications. Physical Review Accelerators and Beams. 28(11).
2.
Guo, Zhiyuan, Shuang Liu, B. Zhou, et al.. (2025). Preclinical tumor control with a laser-accelerated high-energy electron radiotherapy prototype. Nature Communications. 16(1). 1895–1895. 5 indexed citations
3.
Guo, Bo, et al.. (2024). A nomogram to predict the risk of insulin resistance in Chinese women with polycystic ovary syndrome. Frontiers in Endocrinology. 15. 1446827–1446827. 2 indexed citations
4.
Guo, Bo, Tingyun Jiang, Fengchun Wu, et al.. (2022). LncRNA RP5-998N21.4 promotes immune defense through upregulation of IFIT2 and IFIT3 in schizophrenia. SHILAP Revista de lepidopterología. 8(1). 11–11. 9 indexed citations
5.
Guo, Bo, Shanmei Wang, Huifeng Zhang, et al.. (2021). Impact of satellite blood culture on early diagnosis of sepsis. SHILAP Revista de lepidopterología. 2(1). 56–60. 1 indexed citations
7.
Shu, Chi, Haoran Zha, Haixia Long, et al.. (2020). C3a-C3aR signaling promotes breast cancer lung metastasis via modulating carcinoma associated fibroblasts. Journal of Experimental & Clinical Cancer Research. 39(1). 11–11. 49 indexed citations
9.
Zha, Haoran, Xinxin Wang, Ying Zhu, et al.. (2018). Intracellular Activation of Complement C3 Leads to PD-L1 Antibody Treatment Resistance by Modulating Tumor-Associated Macrophages. Cancer Immunology Research. 7(2). 193–207. 79 indexed citations
10.
Wang, Shiyu, Jinchang Liu, Haiyang Yu, et al.. (2016). Protective effects of Weilikang decoction on gastric ulcers and possible mechanisms. Journal of Natural Medicines. 70(3). 391–403. 6 indexed citations
11.
Guo, Bo, et al.. (2015). Expression profile of tumor suppressor gene RASSF1 in lacrimal gland carcinoma. Genetics and Molecular Research. 14(2). 6993–6998. 5 indexed citations
12.
Li, Su‐Xia, Hongli Zhu, Bo Guo, et al.. (2014). [Association of XRCC1 genetic polymorphism with susceptibility to non-Hodgkin's lymphoma].. PubMed. 22(4). 982–7. 1 indexed citations
13.
Han, Xiao, Bo Guo, Yongsheng Li, & Bo Zhu. (2014). Tissue factor in tumor microenvironment: a systematic review. Journal of Hematology & Oncology. 7(1). 54–54. 75 indexed citations
14.
Guo, Bo, et al.. (2013). A randomized guinea pig study on external cell growth factors after fractional ultrapulsed CO2laser therapy. Journal of Cosmetic and Laser Therapy. 15(4). 219–224. 3 indexed citations
15.
Li, Su‐Xia, Hui Fan, Xue-Chun Lu, et al.. (2013). Successful treatment with low-dose decitabine in acute myelogenous leukemia in elderly patients over 80 years old: Five case reports. Oncology Letters. 5(4). 1321–1324. 5 indexed citations
16.
Guo, Bo, Hui Fan, Su‐Xia Li, et al.. (2012). Individualized Fludarabine-Based Regimen in Elderly Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Advances in Therapy. 29(2). 178–186. 1 indexed citations
17.
Guo, Bo, et al.. (2011). Individualized Liposomal Doxorubicin-Based Treatment in Elderly Patients with Non-Hodgkin’s Lymphoma. Onkologie. 34(4). 184–188. 9 indexed citations
18.
Fan, Hui, Hongli Zhu, Suxia Li, et al.. (2010). Efficacy of Amifostine in Treating Patients with Idiopathic Thrombocytopenia Purpura. Cell Biochemistry and Biophysics. 59(1). 7–12. 13 indexed citations
19.
Guo, Bo, et al.. (2010). Prevalence of Dry Eye Disease in Mongolians at High Altitude in China: The Henan Eye Study. Ophthalmic Epidemiology. 17(4). 234–241. 115 indexed citations
20.
Zhang, Lingqi, et al.. (2004). Preliminary study of a vincristine-producing endophytic fungus isolated from leaves of Catharanthus roseus. Zhongcaoyao. 35(1). 79–81. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026